Saudi Central Bank’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$67.4M Buy
56,217
+26,556
+90% +$27.1M 0.88% 24
2026
Q1
$27.3M Buy
29,661
+29,328
+8,807% +$29.7M 0.58% 43
2025
Q4
$358K Hold
333
0.01% 49
2025
Q3
$254K Buy
333
+2
+0.6% +$1.49K 0.01% 51
2025
Q2
$258K Buy
331
+13
+4% +$10.1K 0.01% 53
2025
Q1
$263K Buy
+318
New +$265K 1.39% 12

Other funds holding LLY

Saudi Central Bank's LLY Position: Q2 2026 in Review

Saudi Central Bank increased its Eli Lilly (LLY) stake by 90% in Q2 2026, buying an estimated $27.1M and bringing the position to 56,217 shares worth $67.4M. The position accounts for 0.88% of the portfolio, ranked #24.

Saudi Central Bank first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Saudi Central Bank held 56,217 shares of Eli Lilly worth $67.4M as of Q2 2026.
  • Saudi Central Bank bought 26,556 Eli Lilly shares in Q2 2026, an estimated $27.1M.
  • Eli Lilly made up 0.88% of Saudi Central Bank's portfolio in Q2 2026, its #24 holding.
  • Saudi Central Bank first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Saudi Central Bank's 13F filing for Q2 2026, filed 30 Jul 2026.